Fycompa in Subjects With Small Fiber Neuropathy (SFN)
Status:
Unknown status
Trial end date:
2016-12-01
Target enrollment:
Participant gender:
Summary
This is a Phase II, 2 arm randomized crossover study. Subjects will be assigned to either
active agent or placebo and then crossover to the other arm. This study is designed to
evaluate whether Fycompa improves the quality of life in patients with small fiber
neuropathy.